On August 21, 2007, the USPTO issued final rules (1) limiting the number of continuation applications that can be filed without justification, and also (2) limiting the number of claims that can be presented in a given application without having to provide a detailed patentability analysis.
The USPTO believes that the new rules will improve the patent examination process and relieve the overwhelming backlog of pending patent applications, but may have underestimated the substantive impact the rules will have on patent Applicants.
Reprinted with permission from Portfolio Media, Inc.
Author(s)
Related Insights
July 15, 2025
Innovative Technology Insights
Navigating FDA’s Proposed Guidance on AI and Non-Animal Models: Safeguarding Innovation in Drug Development
In April 2025, the U.S. Food and Drug Administration (FDA) released a landmark guidance titled “Roadmap to Reducing Animal Testing in…
July 15, 2025
Health Care Law Today
Navigating FDA’s Proposed Guidance on AI and Non-Animal Models: Safeguarding Innovation in Drug Development
In April 2025, the U.S. Food and Drug Administration (FDA) released a landmark guidance titled “Roadmap to Reducing Animal Testing in…
July 15, 2025
Health Care Law Today
Colorado Medicaid: RAC Program Overhauled with Enhanced Transparency, Greater Provider Protections, and Increased Oversight
In June 2025, Colorado passed a new law that makes significant changes to the state’s Medicaid Recovery Audit Contractor (RAC) program….